z-logo
open-access-imgOpen Access
Activating internal ribosome entry to treat Duchenne muscular dystrophy
Author(s) -
Shireen R. Lamandé,
Klaus North
Publication year - 2014
Publication title -
nature medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.536
H-Index - 547
eISSN - 1546-170X
pISSN - 1078-8956
DOI - 10.1038/nm.3677
Subject(s) - duchenne muscular dystrophy , dystrophin , internal ribosome entry site , translation (biology) , muscular dystrophy , medicine , genetics , mutation , gene , biology , bioinformatics , messenger rna
Mutations in the DMD gene, encoding dystrophin, cause the most common forms of muscular dystrophy. A new study shows that forcing translation of DMD from an internal ribosome entry site can alleviate Duchenne muscular dystrophy symptoms in a mouse model.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom